Liam Hartwell is a urologist who long ago made peace with the fact that her most useful work often happens in slightly awkward conversations. Erectile dysfunction is common, treatable, and still wrapped in embarrassment, and she has spent her career making the subject ordinary so that people get seen rather than quietly giving up.
In the forum threads her habit is to find the one fact that actually matters in each question and lead with it. Across the whole PDE5 family the non-negotiable is nitrates — prescription or recreational — because combined vasodilation can drop blood pressure to dangerous levels. She says so plainly every time it is relevant, and she links to FDA labelling and AUA guidance when readers want the original wording.
She compares tadalafil, sildenafil and vardenafil without favourites. On efficacy the three drugs land in the same ballpark in registration trials; the choice is pharmacology and lifestyle. Daily low-dose tadalafil suits men who want spontaneity; sildenafil remains the cheapest and longest-studied; vardenafil can be useful when food timing with sildenafil is frustrating. She walks through onset, duration, fat-meal effects, and eye-colour-distortion quirks without ranking one drug as universally best.
Finasteride threads bring a different tone: slower expectations, PSA arithmetic, and honest talk about sexual side effects. She explains why finasteride is not a testosterone booster, why pregnancy is an absolute contraindication, and how prostate trials changed how urologists read PSA on therapy. When readers ask about dutasteride or minoxidil, she maps mechanisms rather than declaring a winner.
She trained at UCSF and completed fellowship at Cleveland Clinic before moving to private practice in Chicago. Her clinic runs a weekly men's-health block where PDE5 trials are discussed with the same graphs she references on the ledger — IIEF-EF, SEP3, GAQ — so patients see the evidence rather than a brand preference.
She covers the three PDE5 inhibitors and finasteride here. As with everything on the site, her answers are general education from a doctor, not a treatment plan written for you.
She sits on her hospital's erectile-dysfunction pathway committee and reviews new PDE5 literature quarterly — when a ledger thread cites a trial, it is usually one she has already flagged for the pathway document.
Her forum replies deliberately repeat the nitrate rule even when the question is about food timing or brand switching, because that is the error that lands people in emergency departments.
She also writes the finasteride threads with the same caution she uses in clinic: PSA doubling on therapy, pregnancy exposure, and the difference between hair-line and crown response on photography.